For more than a century, doctors have known that the deadliest turn in a typhoid fever infection is a perforation of the small intestine, yet the mechanism behind it remained a mystery. Now, researchers at Yale School of Medicine say they have the answer — and it lies not with the bacteria themselves, but with a toxin they release into the bloodstream.

In a study published in Nature Microbiology, the laboratory of Jorge E. Galán reports that typhoid toxin, circulating through the blood, damages the blood vessels of the small intestine. When the bacteria later arrive in the gut, those weakened vessels cannot withstand the assault, leading to perforation. The finding reframes intestinal perforation as a disease of blood vessels rather than a direct bacterial attack on the gut wall.

“This is a problem solved,” said Galán, the Lucille B. Markey Professor of Microbiology and Professor of Cell Biology at Yale School of Medicine.

The discovery completes a line of research that Galán’s lab has pursued since it first identified typhoid toxin in Salmonella Typhi two decades ago. According to Yale News, the new work ties together several puzzling features of the disease: neurological complications that occur even when few bacteria are in the blood, perforation confined to the lower small intestine, and the characteristic loss of circulating white blood cells. All of these, the researchers say, stem from the toxin’s effect on the lining of blood vessels in different parts of the body.

“What ties these very different manifestations together is not the bacterium spreading everywhere, but it is one toxin reaching the vasculature,” Galán said. “The same activity, in a different vascular bed, produces a completely different clinical picture.”

The lab’s experiments, conducted in mice, also provide something the field has long lacked: an animal model in which Salmonella Typhi — a strictly human pathogen — produces the intestinal disease seen in patients. That model, according to Yale News, means researchers can now test antitoxin antibodies, vaccines, and drugs that protect blood vessels against the complication responsible for most typhoid deaths.

“We’re basic scientists, and that our work would have so much direct translational potential is very rewarding,” Galán said.

Typhoid fever continues to kill an estimated 200,000 people annually, primarily in regions where vaccines and effective treatments are scarce, according to Yale News. The elderly and children account for the bulk of fatalities. The new findings suggest a future in which treatments that neutralize the toxin and protect blood vessels could be used alongside antibiotics to clear the bacteria — a combination that has not previously been a realistic prospect.

The lead author of the study was Heng Zhao, a postdoctoral researcher working in the Galán lab. Additional contributors were postdoctoral fellows Canfeng Hua and Jeong In Hur, as well as Maria Lara-Tejero, an associate professor on term, each affiliated with Yale's Department of Microbial Pathogenesis. Funding for the research came from the National Institutes of Health..

For university students studying microbiology, medicine, or global health, the research offers a clear example of how basic science — understanding a fundamental disease mechanism — can open new avenues for treatment. The finding also underscores the importance of funding for long-term research programs: Galán’s lab has worked on typhoid toxin for two decades before reaching this point.